![]()
|
|
||||||||
(Received for publication, April 29, 1997, and in revised form, July 21, 1997)
From the Intoxication of mammalian cells with the
vacuolating toxin (VacA) released by Helicobacter pylori
causes the formation of large acidic vacuoles containing the vacuolar
ATPase proton pump and Rab7, a late endosome marker. Here, we describe
a novel subcellular fractionation procedure, and we show that nanomolar
concentrations of VacA induce a clear redistribution of lysosomal
membrane glycoproteins among endocytic compartments. This
redistribution is an early event in the process of cellular
intoxication by VacA and precedes the formation of macroscopic
vacuoles. The absence of the cation independent mannose 6-P receptor
and the presence of Rab7 and of lysosomal membrane proteins in the
newly formed compartment suggest that the vacuolating toxin induces the
accumulation of a post-endosomal hybrid compartment presenting both
late endosomal and lysosomal features.
Helicobacter pylori, a Gram-negative, spiral-shaped
bacterium colonizing the stomach, is involved in the pathogenesis of
gastritis and gastroduodenal ulcers (1, 2). Recently, such an infection has been associated to MALT lymphomas and to an increased risk of
developing gastric adenocarcinoma (3-6). Even though H. pylori shows a great genetic variability, strains isolated from
human biopsies can be classified into two groups (7). Type I strains are associated with the more serious pathologies and are characterized by the common production of a toxin, termed
VacA,1 and of a
toxin-associated antigen (CagA). Type II strains produce neither of
these two antigens and lack a 40-kilobase pathogenicity island found in
the genome of type I strains (8). VacA is synthesized as a 140-kDa
precursor, which is processed to the mature 95-kDa protein during
export from the bacteria (9-11). Structural features of the toxin (9,
12) hint at the possibility that VacA belongs to the group of bacterial
protein toxins with an A-B type structural organization: protomer B
binds to a membrane receptor present on the surface of target cells and
mediates the translocation of the catalytic A subunit into the cell
cytosol (13).
Intoxication of cells with VacA perturbs the endocytic traffic at a
late stage, and large acidic vacuoles with elements of late endosomal
compartments are formed (14-17). The analysis of the early events of
cellular intoxication and an accurate mapping of the main vacuolar
components will help in determining the intracellular target(s) of VacA
and in understanding the mechanism of cellular intoxication by this
novel bacterial toxin.
Baby hamster kidney (BHK) is a cell line often used in studies of the
endocytic path of higher eucaryotes. The route leading endocytosed
material from the plasma membrane of BHK cells, through the early
endosomal compartment (Rab5+/transferrin
receptor+) to the late endosomal compartment
(Rab7+/cation independent mannose 6-P receptor
(CI-M6PR)+), has been characterized in detail using
electron microscope markers and a range of Rab mutants and/or
endocytosis inhibitors (18-22). However, the distal part of the
endocytic path, connecting late endosomal compartments to lysosomes, is
less characterized (22, 23).
Here, BHK cells exposed to VacA were fractionated with a novel,
isopycnic density ultracentrifugation method, optimized for the
purification of late endosomes and lysosomes from BHK cells. Together
with parallel immunofluorescence staining, this procedure allowed us to
obtain evidence that vacuoles are enriched in lysosomal membrane
markers such as Lgp110, contain low levels of lysosomal hydrolytic
activities, are characterized by the presence of the late endocytic
marker Rab7, but are devoid of another late endosomal marker, the
CI-M6PR. These results indicate that VacA induces the formation and
pathological accumulation of a mixed endo-lysosomal compartment.
Rabbit polyclonal anti-rat CI-M6PR was a kind gift
of Dr. B. Hoflack (Institut Pasteur de Lille, France); rabbit
polyclonal anti-VacA was produced and characterized as described
previously (24); rabbit polyclonal anti-rat Lgp110 was as described in Reaves et al. (29). Rabbit polyclonal antibody to Rab7 was a kind gift of Dr. M. Zerial (EMBL, Heidelberg, Germany). Rabbit anti-human cathepsin D and cathepsin B were purchased from Calbiochem, Texas Red-labeled donkey anti-rabbit was from Amersham Corp. (Little Chalfont, UK). Baby hamster kidney (BHK)
cells were grown in Dulbecco's modified Eagle's medium, 10% fetal
calf serum in an incubator with 5% CO2, at 37 °C.
Twelve to 24 h before the beginning of the experiments, cells were
seeded in Petri dishes with a density of 65-130,000 BHK/cm2. Highly purified VacA was prepared and activated by
short acid exposure as described (24, 25), neutralized by addition of Dulbecco's modified Eagle's medium, 2% fetal calf serum
(intoxication medium), and added to BHK cells. Incubation time was
4 h for all the experiments, the concentration of VacA used is
specified in the description of every experiment. Cell vacuolation as
presented in Fig. 4 was quantified by determining the total neutral red uptake (26).
Fractionation of organelles of BHK cells (treated with 5 nM VacA and mock-treated) by sucrose step gradient was
performed essentially as described (27), in a cold room. Briefly, cells were carefully washed with ice-cold isotonic phosphate buffer, pH 7.4 (PBS), scraped with a rubber policeman, and pelleted by centrifugation
in a table centrifuge (750 rpm, 5 min). They were then resuspended in 3 ml of homogenization buffer (HB-EDTA, 3 mM imidazole, pH
7.4, 250 mM sucrose (8%), 1 mM EDTA, 1 µg/ml antipain, 10 µg/ml aprotinin, 1 µg/ml pepstatin), pelleted (1,500 rpm, 10 min), resuspended in 0.6 ml HB-EDTA, and homogenized by 10-13
passages through a 22-gauge 1[1/4] needle. After centrifugation (2,500 rpm, 15 min) the post-nuclear supernatant (PNS) was collected, and its sucrose concentration increased under stirring to 40.6% by
slow addition of 62% sucrose in HB-EDTA. PNS was then carefully overloaded with 1.5 ml of 35% and 1 ml of 25% sucrose in HB-EDTA. The
tube was filled with HB, and the centrifugation was performed in an
SW55Ti rotor (50,000 rpm, 66 min). The late endosome-enriched fraction
was collected among 25% sucrose and HB (upper interface), the early
endosome-enriched fraction (LE) among 35 and 25% sucrose (middle
interface). The lower interface (40.6/35% sucrose) contained plasma
membrane and other cellular compartments. Endocytic compartments were
characterized by measuring enzymatic activities, by immunofluorescence, and by migration of the purified compartments in density gradients.
Separation of LE and vacuoles from lysosomes and other
cellular compartments was accomplished by self-generated linear
gradients of OptiprepTM. PNS was prepared essentially as
described above, in a buffer containing 20 mM Hepes, pH
7.4, 250 mM sucrose, 1 mM EDTA, 1 µg/ml antipain, 10 µg/ml aprotinin, 1 µg/ml pepstatin. PNS was mixed with
OptiprepTM to a 12.5% working solution and centrifuged to
equilibrium in a NTV90 rotor (76,000 rpm, 130 min). 0.3-ml fractions
were collected from the bottom of the tube with a peristaltic pump;
aliquots were assayed for
After SDS-PAGE, proteins were transferred
onto Immobilon-P membranes (Millipore). Membranes were saturated in 5%
dry milk in TBS (20 mM Tris-HCl, pH 7.6, 133 mM
NaCl) and exposed overnight to primary antibody and for 1 h to
peroxidase-conjugated secondary antibody (diluted in TBS). After
washings with 0.05% Tween 20 in TBS, and with TBS, proteins were
detected using the enhanced chemiluminescence system and a high
performance chemiluminescence film (Amersham Corp., UK). The latter was
scanned with a dual-wavelength Shimadzu CS930 densitometer.
Twenty-four hours before
experiments, BHK cells were seeded with a density of
15,000/cm2 in 75-cm2 Petri dishes containing
glass coverslips and were then treated with 0, 5, and 50 nM
VacA as described above. Coverslips were rinsed with PBS, and cells
were fixed in 3% paraformaldehyde. After 2 short washings with PBS,
0.38% glycine, 0.27% NH4Cl, and 2 additional washings
with PBS, the antigen accessibility was improved by a 30-min incubation
with PBS, 0.2% saponin, 0.5% bovine serum albumin. All antibodies
(anti-VacA, anti-cathepsin D, anti-CI-M6PR, anti-Rab7, anti-Lgp110, and
Texas Red-labeled donkey anti-rabbit) were diluted in the latter
solution.
Vacuoles that form in
HeLa cells exposed to VacA have components such as Rab7 and the
vacuolar H+-ATPase, characteristic of the late endosomal
(LE) compartment (14, 17, 28). These vacuolar structures could arise
and grow either by a homotypic LE fusion or by a heterotypic fusion of
LE with lysosomal or pre-lysosomal vesicles, as recently found for
wortmannin-induced vacuoles (29). In the former case, vacuoles isolated
from VacA-exposed cells should have a protein profile matching that of
LE isolated from control cells, whereas in the case of heterotypic
fusion, the two profiles should be different.
To distinguish between these two possibilities, we compared by SDS-PAGE
the protein profiles of endocytic compartments of BHK cells (exposed to
VacA or mock-treated) isolated by sucrose step gradients. Fig.
1 shows the subtle but reproducible
differences found in the electrophoretic pattern of the fractions
collected from the three interfaces of the flotation gradient. Such
differences (arrows) are restricted to the LE-enriched
fractions, collected from the higher interface of the gradient and
presented in lane 1 (VacA-treated) and lane 2 (control cells). Early endosome-enriched fractions collected from the
middle (lane 3 and 4) and fractions collected
from the lower interfaces (lanes 5 and 6) do not
show appreciable variations. Although VacA treatment of the cells does not lead to significant changes in the distribution of Rab5,
transferrin receptor, Rab7, and CI-M6PR as determined by endocytic
compartments fractionation with this technique (not shown), these
preliminary results represent the first evidence that the toxin
produced by H. pylori induces changes in the protein content
of the LE compartments. Changes could be ascribed to the recruitment of
protein components from other compartments, resulting from heterotypic
fusion events.
These results and the
finding that VacA interferes with Rab7+ endosomal
compartments (16, 17, 28) prompted us to carefully investigate the
distribution of a number of late endocytic and lysosomal markers in
control and in VacA-intoxicated cells. For this purpose, the step
gradient described in the previous section is insufficient because
electron microscopy (27) and immunoblotting (not shown) reveal that at
least part of the cellular population of lysosomes colocalizes with LE
in the upper interface of the flotation gradient. Therefore, we
optimized a self-generating, isopycnic OptiprepTM gradient,
for the clear-cut separation of the late endocytic from the lysosomal
compartment of BHK cells.
PNS was subjected to isopycnic ultracentrifugation and fractions were
collected, denser first, and characterized by immunoblot and enzymatic
activity analysis. Fig. 2 presents the
position in a 12.5% OptiprepTM gradient of some of the
markers tested; acid phosphatase and cathepsin B as lysosomal markers,
Rab7 as LE marker, and
As expected, lysosomes, whose density is the highest among cell
organelles (23), are collected from the bottom of the tube together
with plasma membrane (alkaline phosphatase as marker, not shown) and
trans-Golgi network (see below). Fig. 2 shows that the mature form of
cathepsin B and the major peaks of the lysosomal enzymatic activities
are detected in fractions 1-5 (lysosomes). A minor peak of
To compare cellular vacuoles induced by VacA with those induced by
wortmannin, an inhibitor of phosphatidylinositol 3-kinase, and
described in a previous study (29), we determined the position of the
CI-M6PR, a trans-Golgi network and LE marker, and of Lgp110, a
lysosomal membrane glycoprotein, in the fractions of the isopycnic gradient. In control cells, the CI-M6PR is immunodetected in two regions of the gradient (Fig.
3A) as follows: the denser one
(fractions 2-5) corresponds to membranes derived from the trans-Golgi
network, whereas the lighter, overlapping the distribution of Rab7
(Fig. 3B) and of the minor peak of
Attempts to separate LE from the Lgp110-enriched compartment by
changing the percentage of the OptiprepTM working solution
or the modality of centrifugation were unsuccessful. Hence, it remains
to be established whether VacA-intoxicated cells contain "normal"
LE (Rab7+/CI-M6PR+) together with a distinct
population of Lgp110+ vacuoles with the same density, or
whether VacA induces the formation and accumulation of a
distinct hybrid compartment endowed with both LE and lysosomal components and having a density comparable with
that of LE. The second possibility is supported by the results presented in the following section.
Figs. 5, 6, and
7 show phase contrast (left)
and the corresponding immunofluorescence images (right) of
control and of VacA-treated BHK cells. Immunostaining is specific for
Lgp110 (Fig. 5, B, D, and F), for Rab7
(Fig. 6, B, D, and F), and for CI-M6PR
(Fig. 7, B and D). The phase contrast images of
Fig. 5 show control BHK cells (A), cells exposed to 5 nM VacA (C), and to 50 nM VacA (E). Low nM concentration of VacA does not
induce formation of vacuoles of a size detectable by phase contrast
microscopy nor increases neutral red uptake (Fig. 4). However,
immunofluorescence staining with a Lgp110-specific polyclonal antibody
shows a labeling condensed in enlarged structures that probably
represent vacuoles at an early stage of development. Moreover, as
reported in the previous section, the redistribution of part of the
lysosomal membrane glycoprotein from heavy to lighter fractions can
already be detected by isopycnic gradient centrifugation.
In cells treated with 50 nM VacA, vacuoles are clearly
visible in phase contrast (E) and Lgp110 is clearly
localized on their membrane (F). These cells were also
immunostained for cathepsin D, a protein of the lumen of lysosomes, but
it was not found inside vacuoles (not shown). This could be ascribed to
technical problems, such as its dilution in the vacuolar lumen, which
is larger than that of lysosomes, or to cathepsin loss during cell
fixation. However, this result parallels that obtained with isopycnic
gradients, where redistribution of lysosomal membrane proteins to
lighter fractions is not accompanied by an increase in hydrolytic
activities.
Fig. 6 (D and F) shows that, as for Lgp110, Rab7
is clustered in enlarged structures in cells treated with 5 nM VacA and decorates the membrane of most of the vacuoles
that form upon treatment with 50 nM toxin. On the contrary,
also in highly vacuolated cells, the cellular distribution of the
CI-M6PR does not change (compare B and D of Fig.
7), and interestingly, vacuoles are not labeled. The presence of the
lysosomal marker Lgp110, of the late endosomal marker Rab7, and the
absence of another late endosomal marker (CI-M6PR) clearly indicate the
post-late endosomal origin of VacA-induced vacuoles.
Cell vacuolation is the major detectable activity of VacA, which
determines its name of vacuolating cytotoxin. Previous experiments aimed at the characterization of vacuoles and at the study of the
mechanism of vacuolation employed toxin-enriched bacterial extracts or
high concentrations of purified toxin to emphasize the phenomenon by
inducing a rapid and massive cell vacuolation. In vivo, type
I H. pylori strains release VacA, as clearly deduced from
the presence of anti-VacA antibodies in the serum of infected people or
animal models (30). Although the quantity of the toxin released
in vivo has not yet been determined, vacuoles in number and
dimension comparable with those induced in cultured cells are rarely
detected in human gastric biopsies (31).
Here, cells were exposed to amounts of VacA closer to those experienced
in vivo, which are not sufficient to cause alterations detectable by phase contrast microscopy or by measuring the uptake of
membrane-permeant weak bases such as neutral red. Under these conditions, VacA causes pathological changes in compartments of the
endocytic pathway before vacuoles become apparent. With the aid of
isopycnic density gradient centrifugation, we could follow the
redistribution of Lgp110, a lysosomal membrane glycoprotein, to a
compartment lighter than lysosomes, which also contains Rab7 but not
CI-M6PR nor detectable amounts of cathepsin D. This novel compartment
is acidic and therefore swells when osmotically active weak bases are
present, thus giving rise to the large vacuoles previously associated
to VacA activity. The absence of the CI-M6PR antigen and the presence
of a lysosomal membrane marker identifies vacuoles as post-LE
compartments. Such features are reminiscent of those of the compartment
of antigen presenting cells where antigens are processed and loaded on
MHC-II molecules (32). This raises the interesting possibility that
VacA interferes in the antigen processing and presentation by antigen
presenting cells, thus preventing T cell proliferation, an effect that
would lower the immune response at the level of the stomach mucosa
allowing its colonization by pathogenic strains of H.
pylori.
Remarkably, there appears to be a non-parallel delivery of lumenal and
membrane components of the lysosomes in VacA-induced vacuoles because
they have a low content of hydrolytic enzymes. Such a phenomenon has
already been described in the biogenesis of phagosomes in macrophages
(33).
The precise sequence of events in the terminal part of the endocytic
pathway, which involves LE and lysosomal compartments, is not as well
characterized as that of early endocytic events (23). LE and lysosomes
share several markers, but LE appear to be morphologically more complex
than lysosomes, lighter and endowed with mannose-6-P receptors and Rab7
(34, 35). The presence of a heterogeneous vesicle population linking
CI-M6PR+/Lgp We thank M. de Bernard, E. Papini, and B. Satin for stimulating discussions and Licia Bridda for collaboration in
some of the experiments.
Volume 272, Number 40,
Issue of October 3, 1997
pp. 25339-25344
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
§,
,
and
Centro CNR Biomembrane and Dipartimento di
Scienze Biomediche,
Department of Clinical Biochemistry, University of
Cambridge, Cambridge CB2 2QR, United Kingdom
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
Reagents
-Glucosaminidase and acid phosphatase activities were
determined using
p-nitrophenyl-N-acetyl-
-D-glucosaminide and p-nitrophenyl phosphate disodium (Sigma) as substrates.
OptiprepTM was purchased from Life Technologies, Inc.
(Milan, Italy).
Fig. 4.
VacA activity determined by neutral red
uptake. BHK cells were treated 4 h at 37 °C with the
indicated VacA concentrations in the presence of 5 mM
NH4+. Determination of neutral red
uptake was performed as described (26).
[View Larger Version of this Image (17K GIF file)]
-glucosaminidase and acid phosphatase
activities, and the remaining material was processed for
immunoblotting. In control experiments, LE derived from a flotation
sucrose gradient (Fig. 1, lane 2) were subjected to
isopycnic density centrifugation under the same conditions. SDS-PAGE
analysis showed that LE collected in fractions 7-11, corresponding to
the Rab7+/CI-M6PR+ fractions derived from
isopycnic centrifugation of whole PNS.
Fig. 1.
Changes of the protein pattern in LE-enriched
fractions from flotation sucrose gradients. Silver staining of an
SDS-PAGE. LE-enriched fraction from BHK cells intoxicated with 5 nM VacA (lane 1) and from control BHK cells
(lane 2); early endosome-enriched fraction from
VacA-intoxicated (lane 3) and control cells (lane 4); lower interface of the flotation gradient from
VacA-intoxicated (lane 5) and control cells (lane
6). Additional details are found under "Experimental
Procedures."
[View Larger Version of this Image (89K GIF file)]
Characterization of Vacuoles Originated by VacA Treatment in BHK
Cells by Flotation Sucrose Step Gradient
-glucosaminidase as a marker for both
lysosomes and LE (see Ref. 23 for this choice of markers).
Fig. 2.
Distribution of late endosomal and lysosomal
markers after isopycnic density gradient centrifugation of PNS from BHK
cells. The distribution of acid phosphatase (Ac.
phosphatase) and
-glucosaminidase (top panels)
has been determined by activity measurements, as reported under
"Experimental Procedures." The distribution of cathepsin B and Rab7
has been determined by immunoreactivity of OptiprepTM-derived fractions and quantified by scanning
with a dual-wavelength Shimadzu CS930 densitometer. Experiments were
performed in triplicate.
[View Larger Version of this Image (28K GIF file)]
-glucosaminidase activity is also found in lighter fractions,
afterward identified as LE due to the presence of late endosomal
markers. In the right panels of Fig. 2, the peak of Rab7
immunoreactivity colocalizes (fractions 7-11) with the minor peak of
-glucosaminidase activity. These fractions are therefore enriched in
LE and are clearly separated from the lysosome-containing fractions.
The same analysis was then performed on cells exposed for 4 h to 5 nM VacA, but neither the lysosomal enzymatic activities nor
the markers detected by immunoblot changed significantly their position
in the gradient.
-glucosaminidase (Fig.
2), corresponds to LE compartments. The distribution of Lgp110 in the
same gradient (Fig. 3C) is similar to the distribution of
-glucosaminidase, with a major peak corresponding to lysosomal
fractions and a minor one overlapping the distribution of LE. Although
there is little variation in the distribution of CI-M6PR and of Rab7 in
VacA-treated cells (Fig. 3, A and B), a
consistent portion of Lgp110 shifts from lysosomal fractions
(1-5 in Fig. 3C) to lighter fractions with a density corresponding to that of
Rab7+/CI-M6PR+ LE of control cells
(7-11 in the same figure). This redistribution of
the lysosome membrane glycoprotein Lgp110 is not accompanied by a
comparable redistribution of lysosomal enzymatic activities (see below)
and is evident in cells exposed to VacA at such low concentrations (5 nM) that neither macroscopic vacuoles are visible nor can
an increased uptake of neutral red be measured (26) (Fig. 4). Hence, such redistribution of a
lysosomal membrane protein is an early event in cellular intoxication
by VacA and cannot be attributed to the gross alteration of cell
structure and organization induced by filling the cytosol with large
vacuoles.
Fig. 3.
Distribution of CI-M6PR, Rab7, and Lgp110
after isopycnic density gradient centrifugation of PNS from control
and from VacA-treated BHK cells. PNS from control cells and cells
incubated 4 h with 5 nM VacA were subjected to
isopycnic gradient centrifugation. Fractions were subjected to gel
electrophoresis, and the distribution of CI-M6PR, Rab7, and Lgp110 was
determined by immunoblot and quantified by densitometry. A,
distribution of CI-M6PR. B, distribution of Rab7. The
distribution of these LE markers does not change significantly upon
VacA treatment. C, distribution of Lgp110. The treatment
with low nM toxin concentrations induces an important shift
of Lgp110 immunoreactivity to fractions 8-11. Bars
represent S.D. of two different experiments.
[View Larger Version of this Image (30K GIF file)]
Fig. 5.
Immunofluorescence localization of Lgp110 in
control BHK cells and in cells intoxicated with 5 and 50 nM
VacA. A and B represent phase contrast and
immunofluorescence staining (obtained with Lgp110-specific polyclonal
antibody) of control cells. C-D and E-F are the
corresponding images of cells treated with 5 and 50 nM
VacA, respectively.
[View Larger Version of this Image (80K GIF file)]
Fig. 6.
Immunofluorescence localization of Rab7 in
control BHK cells and in cells intoxicated with 50 nM VacA.
A-F as in Fig. 6; immunofluorescence was with Rab7-specific
polyclonal antibody.
[View Larger Version of this Image (79K GIF file)]
Fig. 7.
Immunofluorescence localization of CI-M6PR in
control BHK cells and in cells intoxicated with 50 nM VacA.
A and B as in Figs. 5 and 6. C and
D cells were treated with 50 nM VacA; immunofluorescence was with CI-M6PR-specific polyclonal antibody.
[View Larger Version of this Image (101K GIF file)]
LE to
CI-M6PR
/Lgp+ lysosomes is known (36). A
recent study postulated the existence of
Rab7+/CI-M6PR
intermediate vesicles, which
bud from perinuclear, CI-M6PR+ LE and fuse with lysosomes
(22). It has also been suggested that lysosomes store mature lysosomal
enzymes that are injected, when needed, in late endosomal compartments
(23). Interestingly, a redistribution of lysosomal membrane
glycoproteins (Lgp110 and Lgp120), similar to the one obtained by VacA,
was recently described as a consequence of the treatment of NRK cells
with wortmannin, an inhibitor of phosphatidylinositol 3-kinase, (29)
which causes the appearance of two swollen late endocytic compartments,
one Lgp+/CI-M6PR
with characteristics similar
to the VacA-induced vacuoles, and one positive for M6PR that was not
found in VacA-treated cells. Reaves et al. (29) have
postulated that the former compartment arises in response to the
wortmannin-induced inhibition of the re-formation of electron dense
lysosomes from a LE/lysosome-hybrid compartment. Similarly, it is
conceivable that treatment with VacA inhibits the retrieval of membrane
to lysosomes, leaving a hybrid compartment that can still fuse with
more lysosomes and therefore swell, particularly in the presence of
membrane-permeant amines. These analogies, first shown in the present
study, suggest the possibility that phosphatidylinositol 3-kinase, is
implicated in the mechanism of VacA intoxication.
*
This work was supported by Ministero Pubblico Instruzione
(40%) and by Human Capital Mobility Grant CHRX CT 920018 (60%).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by a long term EMBO fellowship. To whom correspondence
should be addressed: Centro CNR Biomembrane and Dept. di Scienze
Biomediche, Università di Padova, Via G. Colombo 3, 35100 Padova,
Italy. Fax: 0039-49-8276049; E-mail: toxin{at}civ.bio.unipd.it.
1
The abbreviations used are: VacA, vacuolating
toxin; BHK, baby hamster kidney; CI-M6PR, cation independent mannose
6-P receptor; LE, late endosome(s); Lgp, lysosomal membrane
glycoprotein(s); PNS, post-nuclear supernatant; PBS, phosphate-buffered
saline; PAGE, polyacrylamide gel electrophoresis.
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. R. Castillo, A. J. Woodruff, L. E. Connolly, W. E. Sause, and K. M. Ottemann Recombination-Based In Vivo Expression Technology Identifies Helicobacter pylori Genes Important for Host Colonization Infect. Immun., December 1, 2008; 76(12): 5632 - 5644. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mashima, J. Suzuki, T. Hirayama, Y. Yoshikumi, H. Ohno, H. Ohnishi, H. Yasuda, T. Fujita, and M. Omata Involvement of Vesicle-Associated Membrane Protein 7 in Human Gastric Epithelial Cell Vacuolation Induced by Helicobacter pylori-Produced VacA Infect. Immun., June 1, 2008; 76(6): 2296 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Brumell and M. A. Scidmore Manipulation of Rab GTPase Function by Intracellular Bacterial Pathogens Microbiol. Mol. Biol. Rev., December 1, 2007; 71(4): 636 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Schwartz and L.-A. H. Allen Role of urease in megasome formation and Helicobacter pylori survival in macrophages J. Leukoc. Biol., June 1, 2006; 79(6): 1214 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Letley, J. L. Rhead, K. Bishop, and J. C. Atherton Paired cysteine residues are required for high levels of the Helicobacter pylori autotransporter VacA. Microbiology, May 1, 2006; 152(Pt 5): 1319 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Yamasaki, A. Wada, A. Kumatori, I. Nakagawa, J. Funao, M. Nakayama, J. Hisatsune, M. Kimura, J. Moss, and T. Hirayama Helicobacter pylori Vacuolating Cytotoxin Induces Activation of the Proapoptotic Proteins Bax and Bak, Leading to Cytochrome c Release and Cell Death, Independent of Vacuolation J. Biol. Chem., April 21, 2006; 281(16): 11250 - 11259. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Genisset, C. L. Galeotti, P. Lupetti, D. Mercati, D. A. G. Skibinski, S. Barone, R. Battistutta, M. de Bernard, and J. L. Telford A Helicobacter pylori Vacuolating Toxin Mutant That Fails To Oligomerize Has a Dominant Negative Phenotype Infect. Immun., March 1, 2006; 74(3): 1786 - 1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Das, G. Suarez, E. J. Beswick, J. C. Sierra, D. Y. Graham, and V. E. Reyes Expression of B7-H1 on Gastric Epithelial Cells: Its Potential Role in Regulating T Cells during Helicobacter pylori Infection. J. Immunol., March 1, 2006; 176(5): 3000 - 3009. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Chui, T. M. Clay, H. K. Lyerly, and M. A. Morse The Development of Therapeutic and Preventive Vaccines for Gastric Cancer and Helicobacter pylori Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1883 - 1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fitchen, D. P Letley, P. O'Shea, J. C Atherton, P. Williams, and K. R Hardie All subtypes of the cytotoxin VacA adsorb to the surface of Helicobacter pylori post-secretion J. Med. Microbiol., July 1, 2005; 54(7): 621 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Henderson, F. Navarro-Garcia, M. Desvaux, R. C. Fernandez, and D. Ala'Aldeen Type V Protein Secretion Pathway: the Autotransporter Story Microbiol. Mol. Biol. Rev., December 1, 2004; 68(4): 692 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wada, E. Yamasaki, and T. Hirayama Helicobacter pylori Vacuolating Cytotoxin, VacA, Is Responsible for Gastric Ulceration J. Biochem., December 1, 2004; 136(6): 741 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, A. Wandinger-Ness, J. R. Goldenring, and T. L. Cover Clustering and Redistribution of Late Endocytic Compartments in Response to Helicobacter pylori Vacuolating Toxin Mol. Biol. Cell, April 1, 2004; 15(4): 1946 - 1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakayama, M. Kimura, A. Wada, K. Yahiro, K.-i. Ogushi, T. Niidome, A. Fujikawa, D. Shirasaka, N. Aoyama, H. Kurazono, et al. Helicobacter pylori VacA Activates the p38/Activating Transcription Factor 2-mediated Signal Pathway in AZ-521 Cells J. Biol. Chem., February 20, 2004; 279(8): 7024 - 7028. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Torres, M. S. McClain, and T. L. Cover Interactions between p-33 and p-55 Domains of the Helicobacter pylori Vacuolating Cytotoxin (VacA) J. Biol. Chem., January 16, 2004; 279(3): 2324 - 2331. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Letley, J. L. Rhead, R. J. Twells, B. Dove, and J. C. Atherton Determinants of Non-toxicity in the Gastric Pathogen Helicobacter pylori J. Biol. Chem., July 11, 2003; 278(29): 26734 - 26741. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Suzuki, H. Ohnishi, A. Wada, T. Hirayama, H. Ohno, N. Ueda, H. Yasuda, T. Iiri, Y. Wada, M. Futai, et al. Involvement of Syntaxin 7 in Human Gastric Epithelial Cell Vacuolation Induced by the Helicobacter pylori-produced Cytotoxin VacA J. Biol. Chem., July 3, 2003; 278(28): 25585 - 25590. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yahiro, A. Wada, M. Nakayama, T. Kimura, K.-i. Ogushi, T. Niidome, H. Aoyagi, K.-i. Yoshino, K. Yonezawa, J. Moss, et al. Protein-tyrosine Phosphatase {alpha}, RPTP{alpha}, Is a Helicobacter pylori VacA Receptor J. Biol. Chem., May 23, 2003; 278(21): 19183 - 19189. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Cover, U. S. Krishna, D. A. Israel, and R. M. Peek Jr. Induction of Gastric Epithelial Cell Apoptosis by Helicobacter pylori Vacuolating Cytotoxin Cancer Res., March 1, 2003; 63(5): 951 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. C. Ikonomov, D. Sbrissa, T. Yoshimori, T. L. Cover, and A. Shisheva PIKfyve Kinase and SKD1 AAA ATPase Define Distinct Endocytic Compartments. ONLY PIKfyve EXPRESSION INHIBITS THE CELL-VACUOLATING ACTIVITY OF HELICOBACTER PYLORI VacA TOXIN J. Biol. Chem., November 22, 2002; 277(48): 46785 - 46790. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Patel, D. C. Willhite, R. M. Patel, D. Ye, C. L. Williams, E. M. Torres, K. B. Marty, R. A. MacDonald, and S. R. Blanke Plasma Membrane Cholesterol Modulates Cellular Vacuolation Induced by the Helicobacter pylori Vacuolating Cytotoxin Infect. Immun., August 1, 2002; 70(8): 4112 - 4123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. McClain, P. Cao, H. Iwamoto, A. D. Vinion-Dubiel, G. Szabo, Z. Shao, and T. L. Cover A 12-Amino-Acid Segment, Present in Type s2 but Not Type s1 Helicobacter pylori VacA Proteins, Abolishes Cytotoxin Activity and Alters Membrane Channel Formation J. Bacteriol., November 15, 2001; 183(22): 6499 - 6508. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Prinz, M. Schöniger, R. Rad, I. Becker, E. Keiditsch, S. Wagenpfeil, M. Classen, T. Rösch, W. Schepp, and M. Gerhard Key Importance of the Helicobacter pylori Adherence Factor Blood Group Antigen Binding Adhesin during Chronic Gastric Inflammation Cancer Res., March 1, 2001; 61(5): 1903 - 1909. [Abstract] [Full Text] |
||||
![]() |
N. R. Salama, G. Otto, L. Tompkins, and S. Falkow Vacuolating Cytotoxin of Helicobacter pylori Plays a Role during Colonization in a Mouse Model of Infection Infect. Immun., February 1, 2001; 69(2): 730 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ricci, A. Galmiche, A. Doye, V. Necchi, E. Solcia, and P. Boquet High Cell Sensitivity to Helicobacter pylori VacA Toxin Depends on a GPI-anchored Protein and is not Blocked by Inhibition of the Clathrin-mediated Pathway o |